October 31, 2024 at 12:34 pm

Compass Pathways Restructures Workforce and Adjusts Timeline to Focus on COMP360 Phase 3 Program for Depression; Shares Fall 29%

Compass Pathways (NASDAQ: CMPS) has announced strategic layoffs and operational shifts amid delays in its key clinical program, COMP360, a psychedelic therapy for treatment-resistant depression (TRD). The company is restructuring to concentrate all resources on advancing COMP360, leading to a 30% workforce reduction, including cuts to senior management. The company now expects topline data from… [Read More]
October 31, 2024 at 11:08 am

Street Beats: Magnolia Oil and Gas Reports Q3 Financial Results

The PRISM Oil and Gas Index company Magnolia Oil & Gas (MGY) recently reported Q3 financial results with EPS, EBITDA, and capex beats. Q3 EPS was $0.52 vs FactSet $0.48 and revenue was $333.1M vs FactSet $327.7M. Total production missed while oil production came in slightly above the Street. The company expects Q4 D&C capital… [Read More]
October 31, 2024 at 10:53 am

Anavex’s Blarcamesine Shows Promise in Slowing Alzheimer’s Progression in Phase 2b/3 Trial; Shares up 9%

Anavex Life Sciences (Nasdaq: AVXL) presented data at the 2024 Clinical Trials on Alzheimer’s Disease (CTAD) conference from their Phase 2b/3 trial of blarcamesine (ANAVEX®2-73) in early Alzheimer’s disease (AD) patients. The trial results indicate that the once-daily oral drug met pre-specified efficacy criteria, showing slowed clinical decline and a favorable safety profile without neuroimaging-related… [Read More]
October 30, 2024 at 11:04 am

CorMedix Announces Q3 Earnings That Includes First Full Quarter of DefenCath Sales

Today, CorMedix, Inc. (CRMD) who focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases, announced its Q3 financial results reporting better than expected EPS of ($0.05) vs FactSet ($0.12). CorMedix reported $11.5M in net sales for the quarter, which marks its first full quarter of DefenCath sales… [Read More]
October 30, 2024 at 10:14 am

The Mag 7 Maverick: Alphabet Intends to Fly to the Top of Its AI Game with ‘Goose’ and Reports Blowout Cloud Revenue for Q3

The first of the Mag 7 earnings announcements came yesterday after the close with the release of Alphabet’s (GOOG) Q3 financial results. The company reported Q3 EPS of $2.12 vs FactSet $1.84 and quarterly revenue of $88.3B vs FactSet $86.4Bn. However, one of the most meaningful metrics to the Street was Google Cloud revenue which… [Read More]
October 30, 2024 at 8:48 am

“Freight-ening” Times for Transport As Heartland Express Keeps On Trucking

Trucking company Heartland Express, Inc. (HTLD) reported Q3 financial results that reported disappointing metrics coming in below consensus with EPS of ($0.12) vs FactSet ($0.01) and revenue of $259.9M vs FactSet $268.3M citing a continuation of a challenging freight environment driven by a combination of lower freight demand and excess truck capacity in the marketplace…. [Read More]
October 29, 2024 at 11:31 am

IceCure Medical Gathers Strong Stakeholder Feedback Ahead of FDA Panel Review for ProSense® Cryoablation System; Shares Rise 21%”

IceCure Medical Ltd. (NASDAQ: ICCM) announced that a significant number of public comments from stakeholders, including doctors, nurses, researchers, and breast cancer patients, have been posted ahead of an upcoming FDA Advisory Panel meeting. The panel, scheduled for November 7, 2024, will review and provide recommendations on the benefit-risk profile of IceCure’s ProSense® Cryoablation System… [Read More]
October 29, 2024 at 11:17 am

Talkspace Trades Up ~10% As It Discusses Q3 Earnings Results

PRISM Mental Health Index leader, Talkspace (TALK) who offers psychotherapy and psychiatry services through its platform announced Q3 financial results. The company has traded up ~10% since the release as its third quarter revenue grew by 23% year-over-year (yoy) which was driven by 45% yoy growth in Payor revenue. In addition to its revenue growth, the… [Read More]